19 Jan Novacyt announces initiation of coverage by Invest Securities
Posted at 15:35h
in Novacyt Group
Novacyt (ALTERNEXT: ALNOV), an international specialist in cancer and infectious disease diagnostics, today announces that Invest Securities, an independent investment banking and advisory group, based in Paris, has initiated research coverage of Novacyt.